Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.066 | 0.6 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |